Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Brc Therapeutics Appoints Chandra Ramanathan As Executive Vice President of Commercialization and Strategy

PRIVATEAug 24, 2026•about 4 hours ago

Position

Executive Vice President

Company

BRC Therapeutics

Chandra Ramanathan
CaliforniaBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

BRC Therapeutics has announced the appointment of Chandra Ramanathan, Ph.D., M.B.A., as their new Executive Vice President of Commercialization and Strategy. With over 30 years of experience in biopharmaceuticals, Ramanathan will lead the company's advancement in drug development and commercialization efforts.

Company Information

Company

BRC Therapeutics

Location

California, United States

About

BRC Therapeutics is a clinical-stage pharmaceutical company developing multimodal cannabinoid therapeutics for neurological and inflammatory conditions. The company focuses on innovative science and strong intellectual property to produce FDA-regulated cannabinoid medicines. BRC aims to make a significant difference for patients with unmet medical needs.

Don't miss BRC Therapeutics's next move

Get an email the moment BRC Therapeutics changes its leadership, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for BRC Therapeutics's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

BRC Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.